Group 1 - Marco Digital Technology (01942.HK) has invested $500,000 (approximately HKD 3.925 million) in ALT5 Sigma Corporation (NASDAQ: ALTS) through a fund subscription, indicating a strategic move into the Web3 and DeFi sectors [1] - The investment is seen as an opportunity for capital appreciation and aims to enhance the company's portfolio in the rapidly evolving Web3 and cryptocurrency ecosystem, including digital asset trading and payment solutions [1] - The fund is backed by several major institutional investors and well-known cryptocurrency venture capital firms, with World Liberty Financial, Inc (WLFI) as the lead investor [1] Group 2 - ALT5 is a fintech company that provides next-generation blockchain technology for tokenization, trading, clearing, settlement, payment, and secure custody of digital assets [2] - ALT5 Sigma, Inc., a wholly-owned subsidiary of ALT5, has processed over $5 million in cryptocurrency transactions since its establishment in 2018 [2] - WLFI is an innovative DeFi protocol and governance platform that aims to empower individuals through transparent, convenient, and secure financial solutions, and is behind the USD1 stablecoin, one of the fastest-growing stablecoins globally [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 馬可數字科技控股有限公司 （股份代號：1942） （於開曼群島註冊成立的有限公司） 本公告由馬可數字科技控股有限公司（「本公司」，連同其附屬公司統稱「本集團」） 自願刊發。 本公司董事（「董事」）會（「董事會」）謹此宣佈，本集團近日已透過認購一個基 金（「該基金」）的成員權益間接向ALT5 Sigma Corporation（納斯達克股份代號： ALTS）（「ALT5」）投資500,000美元（約3,925,000港元）（「該投資」）。該基金與多 家全球最大的機構投資者及知名的加密貨幣創投公司共同參與ALT5近期發行（「發 行」），由World Liberty Financial, Inc（「WLFI」）作為領投方。 本集團認為，該投資是一個具有資本增值潛力的投資機會，可加強本集團在Web 3.0（「Web3」）及去中心化金融（「DeFi」）領域的投資組合，從而令本集團可迎接 Web3及加密貨幣生態系統 ...

Group 1 - Eric Trump and Donald Trump Jr. announced a $1.5 billion acquisition of biotech-turned-crypto payment company ALT5 Sigma and a crypto project supported by the Trump family, World Liberty Financial [1] - Point72 and ExodusPoint hedge funds have invested in ALT5 Sigma, with Point72 holding $26.7 million and ExodusPoint reducing its stake to 4.75%, valued at $32.1 million [1] - Despite a 10% drop in ALT5 Sigma's stock price to $5.48, Point72's holdings remain valued at $26.7 million [1] Group 2 - ALT5 Sigma, formerly known as JanOne, underwent a dramatic transformation after facing delisting risks, with its market value previously dropping below $25 million [2] - The company rebranded as a fintech firm and executed a $1.5 billion private placement, with World Liberty Financial injecting 7.5% of its token supply into ALT5 Sigma in exchange for 100 million shares [2] - The stock structure indicates that Trump family-affiliated entities hold 40% of World Liberty's parent company, with Donald Trump Jr., Barron Trump, and Alex Witkoff as co-founders [2]

[PART I. FINANCIAL INFORMATION](index=3&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) [Item 1. Condensed Consolidated Financial Statements](index=3&type=section&id=Item%201.%20Condensed%20Consolidated%20Financial%20Statements) This section presents the unaudited condensed consolidated financial statements for ALT5 Sigma Corporation for the quarterly period ended June 28, 2025, including balance sheets, statements of operations, cash flows, and stockholders' equity, along with detailed notes [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Presents the company's financial position, including assets, liabilities, and equity, as of June 28, 2025, and December 28, 2024 Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | June 28, 2025 | December 28, 2024 | | :--- | :--- | :--- | | **Total Assets** | **$94,686** | **$82,436** | | Total current assets | $33,748 | $35,001 | | Goodwill | $20,131 | $11,714 | | Intangible assets, net | $24,813 | $18,674 | | **Total Liabilities** | **$61,579** | **$53,769** | | Digital assets payable | $23,579 | $30,918 | | Notes payable (Current & Noncurrent) | $21,551 | $11,570 | | **Total Stockholders' Equity** | **$29,251** | **$24,811** | - Total assets increased to **$94.7 million** from **$82.4 million**, primarily driven by a significant rise in Goodwill and Intangible Assets resulting from recent acquisitions. Total liabilities also increased, mainly due to higher Notes Payable[10](index=10&type=chunk) [Condensed Consolidated Statements of Operations and Comprehensive Income](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations%20and%20Comprehensive%20Income) Presents the company's financial performance, including revenues, expenses, and net loss, for the quarterly and year-to-date periods ended June 28, 2025 Statement of Operations Summary (in thousands, except per-share amounts) | Metric | Q2 2025 (13 weeks) | Q2 2024 (13 weeks) | 26 Weeks 2025 | 26 Weeks 2024 | | :--- | :--- | :--- | :--- | :--- | | **Revenues** | **$6,378** | **$2,169** | **$11,892** | **$2,169** | | Gross Profit | $2,775 | $1,098 | $5,366 | $1,098 | | Operating Loss | $(2,095) | $(2,434) | $(3,725) | $(3,584) | | Net (Loss) Income from Continuing Operations | $(5,502) | $970 | $(7,823) | $(653) | | Net Loss from Discontinued Operations | $(3,613) | $(381) | $(4,153) | $(902) | | **Net (Loss) Income** | **$(9,115)** | **$589** | **$(11,976)** | **$(1,555)** | | Net (Loss) Income Per Share, Basic | $(0.49) | $0.07 | $(0.70) | $(0.18) | - Revenues for the 13 and 26 weeks ended June 28, 2025, increased significantly year-over-year, driven by acquisitions in the Fintech segment. However, the company reported a substantial net loss of **$9.1 million** for Q2 2025, compared to a net income of **$0.6 million** in Q2 2024, largely due to a realized loss on exchange transactions and losses from discontinued operations[12](index=12&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Details the company's cash inflows and outflows from operating, investing, and financing activities for the 26-week periods ended June 28, 2025 Cash Flow Summary (in thousands) | Cash Flow Activity | 26 Weeks Ended June 28, 2025 | 26 Weeks Ended June 29, 2024 | | :--- | :--- | :--- | | Net cash used in operating activities | $(6,727) | $(464) | | Net cash provided by investing activities | $122 | $5,853 | | Net cash provided by financing activities | $3,703 | $1,177 | | **Increase in Cash and Cash Equivalents** | **$2,383** | **$5,759** | | Cash and Cash Equivalents, end of period | $9,560 | $5,764 | - For the 26 weeks ended June 28, 2025, the company used **$6.7 million** in cash from operations. Cash from investing activities was minimal at **$0.1 million** from the Mswipe acquisition, a sharp decrease from the prior year's **$5.9 million** which included cash from the ALT-5 acquisition. Financing activities provided **$3.7 million**, primarily from the issuance of notes payable[15](index=15&type=chunk) [Notes to Unaudited Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) Provides detailed explanations of the company's accounting policies, recent acquisitions, segment reporting, and other significant financial disclosures - The company changed its name from 'JanOne Inc.' to 'ALT5 Sigma Corporation' and its ticker from 'JAN' to 'ALTS' effective July 15, 2024[20](index=20&type=chunk) - The company operates in two segments: Fintech and Biotechnology. The Biotechnology segment is now presented as discontinued operations due to a planned spinoff of its subsidiary, Alyea Therapeutics Corporation[21](index=21&type=chunk) - The Fintech segment, which provides blockchain-powered technologies, is the company's core continuing operation. It includes platforms like 'ALT5 Pay' and 'ALT5 Prime' and was expanded through the acquisitions of ALT5 Subsidiary and Mswipe[22](index=22&type=chunk)[23](index=23&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=40&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's financial performance for the 13 and 26-week periods ending June 28, 2025, attributing significant revenue increases to acquisitions and covering segment results, Adjusted EBITDA reconciliation, and liquidity Q2 2025 vs Q2 2024 Performance (in thousands) | Metric | Q2 2025 (13 weeks) | Q2 2024 (13 weeks) | | :--- | :--- | :--- | | Revenue | $6,378 | $2,169 | | Gross Profit | $2,775 | $1,098 | | Net (Loss) Income | $(9,115) | $589 | | Total Adjusted EBITDA | $(1,291) | $(917) | - Revenue for Q2 2025 increased by approximately **$4.2 million** compared to Q2 2024, driven entirely by the acquisitions of ALT5 Subsidiary (May 2024) and Mswipe (May 2025) in the Fintech segment[178](index=178&type=chunk) - The company's cash on hand was **$9.6 million** as of June 28, 2025. Management states that the ability to continue as a going concern depends on future capital raises to fund operations and the development of its biotechnology asset, JAN 123[205](index=205&type=chunk)[206](index=206&type=chunk) Adjusted EBITDA Reconciliation Summary (in thousands) | Period | Net (Loss) Income | Adjusted EBITDA | | :--- | :--- | :--- | | **13 Weeks Ended** | | | | June 28, 2025 | $(9,115) | $(1,291) | | June 29, 2024 | $589 | $(917) | | **26 Weeks Ended** | | | | June 28, 2025 | $(11,976) | $(2,331) | | June 29, 2024 | $(1,555) | $(1,740) | [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=47&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company states that it does not believe there is any significant risk related to interest rate fluctuations on its fixed-rate debt and confirms no holdings of derivative financial instruments or securities for trading or speculative purposes - The company does not believe it has significant risk from interest rate fluctuations on its debt[211](index=211&type=chunk) - The company does not hold any derivative financial instruments or engage in speculative securities trading[212](index=212&type=chunk) [Item 4. Controls and Procedures](index=47&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that as of June 28, 2025, the company's disclosure controls and procedures were not effective due to identified material weaknesses, specifically insufficient written documentation and resources for segregation of duties - The principal executive officer and principal financial officer concluded that the company's disclosure controls and procedures were not effective as of June 28, 2025[214](index=214&type=chunk) - Management identified two material weaknesses in internal control: (1) **Insufficient written documentation of internal control policies and procedures**, and (2) **Insufficient resources to maintain adequate segregation of duties**[218](index=218&type=chunk) [PART II. OTHER INFORMATION](index=49&type=section&id=PART%20II.%20OTHER%20INFORMATION) [Item 1. Legal Proceedings](index=49&type=section&id=Item%201.%20Legal%20Proceedings) This section refers to Note 15 of the financial statements for information on legal proceedings, including a settled SEC complaint and ongoing cases - Information regarding legal proceedings is detailed in Note 15 of the Consolidated Financial Statements[224](index=224&type=chunk) [Item 1A. Risk Factors](index=49&type=section&id=Item%201A.%20Risk%20Factors) As a smaller reporting company, ALT5 Sigma is not required to provide this information but has chosen to supplement its previous disclosures from the 2024 Form 10-K, particularly in light of the SEC Complaint - The company is a smaller reporting company and is not required to provide risk factors, but has chosen to supplement its previous disclosures from the 2024 10-K[225](index=225&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=49&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities or use of proceeds during the period - None reported for the period[226](index=226&type=chunk)

美股是有什么我们看不懂的坑么，为什么 $ALTS 增发发行价 7.5今天能继续砸到 6 去，团队出货了？这个时间有出货动机吗有没有懂的说说 ...

[Securities Purchase Agreement Overview](index=1&type=section&id=Securities%20Purchase%20Agreement) This agreement outlines ALT5 Sigma Corporation's private placement offering to raise up to $1.5 billion, including concurrent Registration Rights and Token Purchase Agreements [Agreement Parties and Offering](index=1&type=section&id=Agreement%20Parties%20and%20Offering) The agreement, dated August 11, 2025, details ALT5 Sigma Corporation's private placement to raise up to $1.5 billion, involving specific securities and a concurrent token purchase - The agreement is dated **August 11, 2025**, between ALT5 Sigma Corporation and the purchasers identified on the signature pages[2](index=2&type=chunk) Offering Details | Offering Detail | Value / Description | | :--- | :--- | | **Maximum Gross Proceeds** | Up to **$1.5 billion** | | **Offering Basis** | Commercially reasonable best efforts | | **Securities Act Exemption** | Section 4(a)(2) and Rule 506(b) of Regulation D | - Contemporaneously with this offering, the parties will execute a Registration Rights Agreement and a Token Purchase Agreement, under which the Company will purchase **$WLFI** from the Lead Investor[3](index=3&type=chunk) - The purchase of securities is intended to be treated as a tax-free exchange under **Section 351(a)** of the Internal Revenue Code[4](index=4&type=chunk) [Article I: Definitions](index=1&type=section&id=ARTICLE%20I.%20DEFINITIONS) This article defines key terms, including the $7.50 per share purchase price, the Lead Investor, and the various securities offered [Key Definitions](index=1&type=section&id=1.1%20Definitions) Key terms defined include the $7.50 per share price, World Liberty Financial as Lead Investor, and the various common stock and warrant securities - The "Per Share Purchase Price" for the Common Stock is established at **$7.50**[37](index=37&type=chunk) - The "Lead Investor" is identified as **World Liberty Financial, Inc.**[30](index=30&type=chunk) - The "Securities" being sold include Shares of Common Stock, Pre-Funded Warrants, Lead Investor Warrants, Management Warrants, and the shares issuable upon their exercise[53](index=53&type=chunk) - The agreement defines several stablecoins that can be used for payment: **USD1** (World Liberty Financial USD coin), **USDC** (USD Coin), and **USDT** (Tether)[50](index=50&type=chunk)[51](index=51&type=chunk)[52](index=52&type=chunk) - The "Placement Agent" for the offering is **A.G.P./Alliance Global Partners**[39](index=39&type=chunk) [Article II: Purchase and Sale](index=7&type=section&id=ARTICLE%20II.%20PURCHASE%20AND%20SALE) This article details the closing terms, including share sales, beneficial ownership limits, payment methods, and required deliverables [Closing](index=7&type=section&id=2.1%20Closing) The closing involves selling up to $750 million in shares, with options for Pre-Funded Warrants and payment in cash or specified stablecoins/tokens Transaction Closing Details | Item | Detail | | :--- | :--- | | **Aggregate Purchase** | Up to **~$750 million** of Shares | | **Beneficial Ownership Limitation** | 4.99% or 9.99% (at Purchaser's election) | | **Payment Methods** | Cash, USD1, USDT, USDC, or $WLFI | | **$WLFI Fixed Exchange Rate** | **$0.20** per **$WLFI** token | - Purchasers may elect to purchase Pre-Funded Warrants in lieu of Shares to manage their beneficial ownership percentage[65](index=65&type=chunk) [Deliveries](index=8&type=section&id=2.2%20Deliveries) This section specifies the Company's provision of executed documents and warrants, and Purchasers' delivery of agreements and subscription amounts - Company's deliverables include the executed Agreement, legal opinions, irrevocable instructions to the Transfer Agent, various Warrants (Pre-Funded, Asset Manager, Lead Investor, Management), and other related agreements[66](index=66&type=chunk) - Purchasers' deliverables include the executed Agreement, the Registration Rights Agreement, the TPA (from Lead Investor), and the Subscription Amount in the specified form (cash or crypto)[66](index=66&type=chunk) [Closing Conditions](index=9&type=section&id=2.3%20Closing%20Conditions) Closing is contingent on accurate representations, covenant fulfillment, and required deliveries, with additional conditions for Purchasers regarding material adverse effects - The Company's obligation to close is subject to the accuracy of Purchasers' representations and their performance of all obligations[67](index=67&type=chunk) - The Purchasers' obligation to close is subject to the accuracy of the Company's representations, its performance of obligations, the absence of a Material Adverse Effect, and that the Company's stock has not been suspended from trading[67](index=67&type=chunk) [Article III: Representations and Warranties](index=10&type=section&id=ARTICLE%20III.%20REPRESENTATIONS%20AND%20WARRANTIES) This article covers the Company's and Purchasers' assurances regarding corporate status, financial compliance, and investment intent [Representations and Warranties of the Company](index=10&type=section&id=3.1%20Representations%20and%20Warranties%20of%20the%20Company) The Company warrants its SEC compliance, non-investment company status, valid securities issuance, and the governance-only utility of $WLFI tokens - The Company represents that its **SEC Reports** are filed on time, comply with regulations, and do not contain any untrue statements of a material fact[77](index=77&type=chunk) - The Company confirms it is not an "investment company" under the **Investment Company Act of 1940** and will conduct its business to avoid becoming one[91](index=91&type=chunk) - The Company represents that, assuming the accuracy of the Purchasers' representations, the offering is a private placement exempt from registration under the **Securities Act**[90](index=90&type=chunk) - The Company acknowledges that the sole utility of the **$WLFI** token is for governance participation in the World Liberty Financial Protocol and that it does not confer economic rights or represent an expectation of profits[116](index=116&type=chunk) [Representations and Warranties of the Purchasers](index=21&type=section&id=3.2%20Representations%20and%20Warranties%20of%20the%20Purchasers) Purchasers confirm their accredited investor status, acquisition for own account, and clear title to any digital assets used for payment - Each Purchaser represents they are an "**accredited investor**" as defined under the Securities Act[125](index=125&type=chunk) - Each Purchaser confirms they are acquiring the Securities for their own account and not as a result of any "general solicitation" or "general advertising"[124](index=124&type=chunk)[127](index=127&type=chunk) - Purchasers paying with digital assets (**USD1**, **USDC**, **USDT**, or **$WLFI**) represent that they have full rights and title to the assets, which are held in a secure digital wallet under their exclusive control[131](index=131&type=chunk) [Article IV: Other Agreements of the Parties](index=23&type=section&id=ARTICLE%20IV.%20OTHER%20AGREEMENTS%20OF%20THE%20PARTIES) This article outlines ongoing covenants, including disclosure, equity sales, Lead Investor board rights, and the $WLFI-centric Treasury Reserve Policy [Covenants and Post-Closing Obligations](index=23&type=section&id=Covenants%20and%20Post-Closing%20Obligations) Key covenants include public disclosure, use of proceeds for $WLFI acquisition, board nomination rights for Lead Investor, and adoption of a $WLFI-focused Treasury Reserve Policy - The Company is required to issue a press release and file a **Form 8-K** to publicly disclose the transaction, after which the Purchasers are released from confidentiality obligations[144](index=144&type=chunk) - Net proceeds from the sale will be used to acquire **$WLFI** and establish the company's cryptocurrency treasury operations, managed by an Asset Manager[147](index=147&type=chunk) - The Company agrees to seek stockholder approval to increase its authorized shares to ensure sufficient reserves for warrant exercises, with a meeting to be held by **September 30, 2025**[151](index=151&type=chunk) - The Lead Investor obtains the right to nominate **two directors** to the Company's board (including the Chairman) and to select the Chief Investment Officer[162](index=162&type=chunk) - The Company will adopt a "**Treasury Reserve Policy**" making **$WLFI** its primary treasury reserve asset, with oversight from a board subcommittee chaired by a Lead Investor director[163](index=163&type=chunk) - The parties agree to treat the transaction as a tax-free exchange under **Section 351(a)** of the IRC, with **$WLFI** valued at **$0.20 per token** for tax purposes[165](index=165&type=chunk)[166](index=166&type=chunk) [Article V: Miscellaneous](index=33&type=section&id=ARTICLE%20V.%20MISCELLANEOUS) This article covers general legal provisions, including termination conditions, expense allocation, governing law, and waiver of jury trial [General Provisions](index=33&type=section&id=General%20Provisions) Standard clauses include termination rights, expense reimbursement, New York governing law, and a mutual waiver of jury trial for disputes - A Purchaser may terminate their obligation if the Closing has not occurred on or before the **seventh Trading Day** following the agreement's date[170](index=170&type=chunk) - The Company agrees to reimburse the Lead Investor for up to **$1,000,000** in costs and expenses related to the transaction[171](index=171&type=chunk) - The agreement shall be governed by the internal laws of the **State of New York**, with legal proceedings to be commenced in New York City courts[178](index=178&type=chunk) - All parties knowingly and irrevocably waive their right to a **trial by jury** in any action, suit, or proceeding related to the agreement[190](index=190&type=chunk) [Exhibits](index=40&type=section&id=Exhibits) This section lists the ancillary documents forming part of the agreement, including the Registration Rights Agreement and various warrant forms [Attached Exhibits](index=40&type=section&id=Attached%20Exhibits) The agreement incorporates key exhibits such as the Registration Rights Agreement, various lock-up agreements, and forms for different warrant types - The agreement references and includes the following key exhibits: * **Exhibit A:** Registration Rights Agreement * **Exhibit B:** Form of Management Lock-Up Agreement * **Exhibit C:** Form of Pre-Funded Warrant * **Exhibit D:** Form of Lead Investor Warrant * **Exhibit E:** Form of Management Warrant * **Exhibit F:** Token Purchase Agreement * **Exhibit G:** Investor Lock-Up Agreement[196](index=196&type=chunk)[197](index=197&type=chunk)[198](index=198&type=chunk)

Core Insights - ALT5 Sigma Corporation has partnered with Voltage to enable Lightning Network payment capabilities, facilitating instant and low-cost Bitcoin transactions for global merchants and financial institutions [1][2][3] Company Overview - ALT5 Sigma is a fintech company focused on blockchain-powered payment and trading infrastructure, processing over $5 billion in cryptocurrency transactions since its inception [6][7] - The company offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform [8][9] Industry Trends - The integration of Lightning Network is seen as a strategic move to meet the growing demand for faster settlement and lower fees in the digital economy [2][3] - There is an increasing interest in stablecoin settlement over Lightning, presenting new opportunities for financial platforms [4] Technological Advancements - The Lightning Network integration allows for real-time Bitcoin transactions, enhancing speed, reliability, and cost-efficiency for high-frequency digital payments [3] - ALT5's infrastructure aims to provide scalable and secure solutions for bridging digital assets with traditional financial workflows [5]

Financial Results - ALT5 Sigma Corporation reported its financial results for the fiscal first quarter ended March 29, 2025[8]. - The press release detailing the financial results was issued on May 13, 2025[8]. - The financial statements and exhibits related to the report are included as Exhibit 99.1[11]. Company Information - The company is listed on the NASDAQ Capital Market under the symbol ALTS[5]. - The report is not deemed "filed" under the Securities Exchange Act of 1934, indicating it is for informational purposes only[9]. - The report was signed by CEO Peter Tassiopoulos on May 14, 2025[14].

Revenue and Profitability - Revenue for the 13 weeks ended March 29, 2025, was $5.514 million, an increase of approximately $5.5 million compared to the same period in 2024, attributed to the acquisition of ALT5 Subsidiary[130] - Gross profit for the same period was $2.591 million, representing a gross profit margin of 47.0%[129] - Adjusted EBITDA for the 13 weeks ended March 29, 2025, was $(162,000), an improvement of approximately $331,000 or 67.1% compared to $(493,000) in the prior year[142] - The Fintech segment generated revenue of $5.514 million with an operating loss of approximately $360,000 for the 13 weeks ended March 29, 2025[139] - The company reported a net loss of approximately $2.1 million for the 13 weeks ended March 29, 2025, compared to a net loss of approximately $2.9 million for the same period in 2024, primarily due to increased costs associated with the acquisition of ALT5 Subsidiary[148] Expenses and Costs - Selling, general and administrative expenses increased by approximately $3.0 million to $4.761 million for the 13 weeks ended March 29, 2025, primarily due to the acquisition of ALT5 Subsidiary[132] - Interest expense, net increased by approximately $470,000 to $720,000 for the 13 weeks ended March 29, 2025, primarily due to the acquisition of ALT5 Subsidiary[133] - The Biotechnology segment generated no revenue for the 13 weeks ended March 29, 2025, and selling, general and administrative expenses increased due to amortization costs[140] Cash Flow and Financing - Cash on hand as of March 29, 2025, was $10.8 million, with plans to raise funds for future development of JAN 123[143] - Cash used in operations was approximately $1.5 million for the 13 weeks ended March 29, 2025, compared to cash provided by operations of approximately $544,000 in the same period of 2024[145] - Cash provided by financing activities was $1.5 million for the 13 weeks ended March 29, 2025, related to proceeds from the issuance of notes payable and warrants converted to common stock[147] - The company may require additional debt financing and/or capital to finance new acquisitions and conduct Phase IIb clinical trials[149] Assets and Liabilities - Total current assets are approximately $31.8 million, while total current liabilities are approximately $38.2 million, resulting in a net negative working capital of approximately $6.4 million[148] Future Plans and Risks - The company plans to capitalize a subsidiary with certain biotechnology assets and acquire an additional biotechnology asset to support future operations[143] - The company does not believe there is any significant risk related to interest rate fluctuations on its short and long-term fixed rate debt[150] - The company does not hold any derivative financial instruments or securities for trading or speculative purposes[151]

Financial Performance - ALT5 Sigma achieved record Q4 revenue of $5.4 million and total fiscal 2024 revenue of $12.53 million for its Fintech segment[4][12]. - The Fintech segment reported a strong annual gross margin of 50.2% and an impressive adjusted EBITDA of 18.2%[2][12]. - The Fintech segment's adjusted EBITDA for Q4 was approximately $1.03 million[12]. - ALT5 Sigma, Inc. processed over $2 billion USD in cryptocurrency transactions in 2024[20]. Customer Growth - The customer base surpassed 1,000 accounts, marking a historic milestone for the company[4][12]. Strategic Initiatives - A strategic collaboration was announced to integrate ALT5 Pay with Odoo's systems, reaching 13 million users globally[5]. - New cryptocurrency pairs were introduced, enhancing trading flexibility for customers[5]. - ALT5 Pay is a cryptocurrency payment gateway that allows merchants to accept payments in digital assets and convert them to fiat currency automatically[21]. - ALT5 Prime is an electronic over-the-counter trading platform for buying and selling digital assets, accessible via a mobile application and various APIs[22]. Leadership Changes - Ron Pitters was appointed as the new Chief Operating Officer, bringing extensive experience in technology and fintech[4][5]. Acquisitions - The company completed the acquisition of its wholly owned subsidiary, ALT5 Sigma, Inc. in May 2024[5]. Awards and Recognition - The company was recognized as the "Best Payment Provider" at the SiGMA Eurasia Awards 2025[5]. Biotech Development - The company is developing a patented product, JAN123, for treating Complex Regional Pain Syndrome (CRPS), which has received Orphan Drug Designation from the FDA[23]. - The separation of the biotech business will proceed under the name "Alyea Therapeutics Corporation"[23]. Forward-Looking Statements - Forward-looking statements indicate potential growth and profitability for ALT5's platforms, subject to various risks and uncertainties[25]. - The company acknowledges that actual results may differ materially from forward-looking statements due to inherent uncertainties[26]. - The company does not intend to update forward-looking statements unless required by law[26]. - Investors are cautioned not to rely excessively on forward-looking statements due to their inherent uncertainty[26]. Investor Relations - Media and investor relations contact information is provided for further inquiries[27].